Rubicon Research Limited (BOM:544578)
772.50
+4.90 (0.64%)
At close: Mar 30, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 127.32 billion as of March 30, 2026.
Market Cap
127.32B
Enterprise Value
131.48B
Revenue
15.98B
Ranking
n/a
PE Ratio
61.75
Stock Price
772.50
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 127.32B, an increase of 23.02%. That is a compound annual growth rate of 58.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 127.32B | 13.52% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 330.39B |
| AstraZeneca Pharma India | 198.65B |
| Granules India | 154.44B |
| Jubilant Pharmova | 133.73B |
| Rubicon Research | 126.50B |
| Caplin Point Laboratories | 118.37B |
| CORONA Remedies | 96.72B |
| Viyash Scientific | 81.72B |